Growth Metrics

Silence Therapeutics (SLN) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $75000.0.

  • Silence Therapeutics' Amortizatization of Intangibles rose 62154.22% to $75000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $271000.0, marking a year-over-year increase of 17959.83%. This contributed to the annual value of $257000.0 for FY2024, which is 198.41% up from last year.
  • As of Q3 2025, Silence Therapeutics' Amortizatization of Intangibles stood at $75000.0, which was up 62154.22% from $67000.0 recorded in Q2 2025.
  • Silence Therapeutics' Amortizatization of Intangibles' 5-year high stood at $75000.0 during Q3 2025, with a 5-year trough of $1178.5 in Q3 2022.
  • In the last 5 years, Silence Therapeutics' Amortizatization of Intangibles had a median value of $10782.4 in 2023 and averaged $23800.5.
  • As far as peak fluctuations go, Silence Therapeutics' Amortizatization of Intangibles tumbled by 8053.79% in 2022, and later soared by 134936.93% in 2023.
  • Over the past 5 years, Silence Therapeutics' Amortizatization of Intangibles (Quarter) stood at $2696.0 in 2021, then tumbled by 56.29% to $1178.5 in 2022, then skyrocketed by 847.81% to $11170.4 in 2023, then surged by 472.94% to $64000.0 in 2024, then increased by 17.19% to $75000.0 in 2025.
  • Its Amortizatization of Intangibles was $75000.0 in Q3 2025, compared to $67000.0 in Q2 2025 and $65000.0 in Q1 2025.